Compounds > arginine

arginine and Graft vs Host Disease

arginine has been researched along with Graft vs Host Disease in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (44.44)	18.2507
2000's	1 (11.11)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Anczurowski, M; Arrowsmith, CH; Butler, MO; Guo, T; Hirano, N; Kagoya, Y; Matsunaga, Y; Murata, K; Saijo, H; Saso, K; Sugata, K; Wang, CH	1
Beelen, D; Dai, H; Dreger, P; Kordelas, L; Kumar, R; Luft, T; Müller-Tidow, C; Rachakonda, SP; Radujkovic, A	1
Bloem, AC; de Kort, RA; Lokhorst, HM; Mutis, T; Spaapen, RM; van den Oudenalder, K; van Elk, M	1
de la Torre, A; Demeocq, F; Farges, MC; Goncalves-Mendes, N; Hannani, D; Kanold, J; Laroye, H; Merlin, E; Vasson, MP	1
Drobyski, WR; Griffith, OW; Hanson, GA; Keever, CA; McAuliffe, T	1
Dull, KE; Hoffman, RA; Ildstad, ST; Langrehr, JM; McCarthy, SA; Simmons, RL; Wren, SM	1
Byon, JC; Delmonte, J; Falzarano, G; Ferrara, JL; Krenger, W; Snyder, KM	1
Garside, P; Hutton, AK; Liew, FY; Mowat, AM; Severn, A	1
Cheng, HY; Li, TT; Wang, JB; Wang, WJ; Yang, F; Yang, YX; Zhang, YF	1

Trials

1 trial(s) available for arginine and Graft vs Host Disease

Article	Year
Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation. Haematologica, 2019, Volume: 104, Issue:4 Topics: Allografts; Arginine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Risk Factors; Survival Rate	2019

Other Studies

8 other study(ies) available for arginine and Graft vs Host Disease

Article	Year
Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. Journal of autoimmunity, 2019, Volume: 97 Topics: Animals; Arginine; Biomarkers; Cell Line; Cytokines; Disease Models, Animal; Fluorescent Antibody Technique; Forkhead Transcription Factors; Gene Expression Profiling; Graft vs Host Disease; Humans; Kaplan-Meier Estimate; Male; Methylation; Mice; Mutation; Protein Processing, Post-Translational; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory	2019
Rapid identification of clinical relevant minor histocompatibility antigens via genome-wide zygosity-genotype correlation analysis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23 Topics: Alleles; Arginine; CD4-Positive T-Lymphocytes; Genome; Genotype; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Membrane Transport Proteins; Minor Histocompatibility Antigens; Models, Genetic; Multiple Myeloma; Peptides; Phenotype; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein	2009
Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. Transplant immunology, 2011, Jan-15, Volume: 24, Issue:2 Topics: Adolescent; Adult; Arginase; Arginine; Cells, Cultured; Child; Enzyme Induction; Female; Graft vs Host Disease; Humans; Immune Tolerance; Interferon-gamma; Interleukin-10; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Ornithine; Photopheresis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha	2011
Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood, 1994, Oct-01, Volume: 84, Issue:7 Topics: Amino Acid Oxidoreductases; Animals; Arginine; Body Weight; Bone Marrow; Bone Marrow Transplantation; Graft Survival; Graft vs Host Disease; Mice; Mice, Inbred AKR; Minor Lymphocyte Stimulatory Antigens; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Spleen; Survival Analysis	1994
Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease. Journal of immunology (Baltimore, Md. : 1950), 1993, Aug-01, Volume: 151, Issue:3 Topics: Animals; Arginine; Concanavalin A; Female; Graft vs Host Disease; Immune Tolerance; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred Strains; Nitrates; Nitric Oxide; Nitrites; omega-N-Methylarginine; Peritoneal Cavity; Trinitrobenzenes	1993
Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood, 1996, Aug-01, Volume: 88, Issue:3 Topics: Acute Disease; Animals; Arginine; Bone Marrow Transplantation; Concanavalin A; Enzyme Activation; Enzyme Inhibitors; Female; Graft vs Host Disease; Interferon-gamma; Interleukin-4; Isoantigens; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mitogens; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Radiation Chimera; Spleen; T-Lymphocytes	1996
Nitric oxide mediates intestinal pathology in graft-vs.-host disease. European journal of immunology, 1992, Volume: 22, Issue:8 Topics: Animals; Arginine; Cell Division; Female; Graft vs Host Disease; Intestines; Killer Cells, Natural; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Nitric Oxide; omega-N-Methylarginine; Tumor Necrosis Factor-alpha	1992
Teniposide-intensified hematopoietic stem cell transplantation with acute graft versus host disease prophylaxis with anti-thymocyte globulin provides good results in high-risk or refractory recurrent hematopoietic malignant diseases. Annals of palliative medicine, 2021, Volume: 10, Issue:11 Topics: Antilymphocyte Serum; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Retrospective Studies; Teniposide	2021